ThickenUp® Gel Express for Patients with Dysphagia
NCT04741581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2024-09-19
Summary
Evaluation of swallowing function and hydration following consumption of ThickenUp® Gel Express in patients with dysphagia.
Conditions
- Dysphagia, Esophageal
Interventions
- DIETARY_SUPPLEMENT
-
ThickenUp® Gel Express
Thickening gel
Sponsors & Collaborators
-
Société des Produits Nestlé (SPN)
lead INDUSTRY
Principal Investigators
-
Pere Clavé, MD, PhD · Hospital de Mataró
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-11
- Primary Completion
- 2022-05-31
- Completion
- 2022-05-31
Countries
- Spain
Study Locations
More Related Trials
-
Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia
NCT02959450 ·Status: COMPLETED ·Phase: NA
-
Impact of Glossopharyngeal Nerve Block on Swallowing Difficulties Caused by Gastroesophageal Reflux Disease
NCT06328205 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
NCT02353078 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Stellate Ganglion Block on Gastroesophageal Reflux Disease
NCT06319521 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Improving Diagnostic Standards in Dysphagia
NCT04773184 ·Status: COMPLETED
-
Capsule Sponge Study in Eosinophilic Oesophagitis
NCT06501274 ·Status: RECRUITING ·Phase: NA
-
Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease
NCT06215794 ·Status: WITHDRAWN ·Phase: NA
-
Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
NCT03411252 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With Dysphagia
NCT00001718 ·Status: COMPLETED ·Phase: NA
-
Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD
NCT01453985 ·Status: UNKNOWN ·Phase: NA
-
Long Term Outcome of Argon Plasma Coagulation of Cervical Heterotopic Gastric Mucosa as an Alternative Treatment for Globus Sensations
NCT01574755 ·Status: COMPLETED
-
Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients
NCT05579587 ·Status: WITHDRAWN
-
Subacute Effect of Pharyngeal Pharmacological Sensory Stimulation in Elderly Patients With Oropharyngeal Dysphagia
NCT04741620 ·Status: COMPLETED ·Phase: NA
-
Effect of Lidocaine Block on Gastroesophageal Reflux Disease
NCT06304142 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Topical Bethanechol for Improvement of Esophageal Dysmotility
NCT01031043 ·Status: COMPLETED ·Phase: PHASE1
-
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
NCT01118585 ·Status: COMPLETED ·Phase: NA
-
ACHAT-STUDY, Alternative Treatment of Chronic Globus Sensations
NCT00439439 ·Status: COMPLETED ·Phase: NA
-
A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice
NCT07004439 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy & Safety of Submucosal Endoscopic Myotomy With Mucosal Flap (SEMF) in the Treatment of Patients With Achalasia
NCT01438398 ·Status: COMPLETED ·Phase: NA
-
A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy
NCT01845454 ·Status: TERMINATED ·Phase: NA
-
Effect of Full-thickness Gastroplication With the GERD-X System on Atypical Gastro-esophageal-reflux-symptoms
NCT02181855 ·Status: UNKNOWN ·Phase: NA
-
AspiRATE: Novel Intervention to Acoustically Detect Silent Aspiration in Acquired Dysphagia.
NCT03676582 ·Status: COMPLETED
-
Food Antigen in Eosinophilic Esophagitis
NCT02434705 ·Status: COMPLETED
-
Reference Values for Videofluoroscopic Measures of Swallowing
NCT05497219 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Lingual Tonsil Hypertrophy Grading and Its Relation to Sociodemographic Factors and Clinical Symptoms
NCT02926014 ·Status: COMPLETED ·Phase: NA